Transplantation elicits a clonally diverse CD8+T cell response that is comprised of potent CD43+effectors

被引:2
|
作者
Cohen, Gregory S. [1 ]
Kallarakal, Melissa A. [1 ]
Jayaraman, Sahana [1 ]
Ibukun, Francis I. [1 ]
Tong, Katherine P. [2 ]
Orzolek, Linda D. [3 ]
Larman, H. Benjamin [1 ]
Krummey, Scott M. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA
[3] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
来源
CELL REPORTS | 2023年 / 42卷 / 08期
关键词
CD8(+) T-CELLS; PRECURSOR FREQUENCY; IMMUNE-RESPONSE; ACUTE REJECTION; MEMORY; RECEPTOR; NAIVE; CD43; AFFINITY; INFLAMMATION;
D O I
10.1016/j.celrep.2023.112993
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD8+ T cells mediate acute rejection of allografts, which threatens the long-term survival of transplanted organs. Using MHC class I tetramers, we find that allogeneic CD8+ T cells are present at an elevated naive precursor frequency relative to other epitopes, only modestly increase in number after grafting, and maintain high T cell receptor diversity throughout the immune response. While antigen-specific effector CD8+ T cells poorly express the canonical effector marker KLRG-1, expression of the activated glycoform of CD43 defines potent effectors after transplantation. Activated CD43+ effector T cells maintain high expression of the coreceptor induced T cell costimulator (ICOS) in the presence of CTLA-4 immunoglobulin (Ig), and dual CTLA-4 Ig/anti-ICOS treatment prolongs graft survival. These data demonstrate that graft-specific CD8+ T cells have a distinct response profile relative to anti-pathogen CD8+ T cells and that CD43 and ICOS are critical surface receptors that define potent effector CD8+ T cell populations that form after transplantation.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Decoding Immunodominance of an Antiviral CD8+T Cell Response
    Kotturi, Maya
    Scott, Iain
    Wolfe, Tom
    Peters, Bjoern
    Sidney, John
    von Herrath, Matthias G.
    Buchmeier, Michael J.
    Grey, Howard
    Sette, Alessandro
    FASEB JOURNAL, 2008, 22
  • [2] Kinetic evolution of a diabetogenic CD8+T cell response
    Santamaria, P
    IMMUNOLOGY OF DIABETES II: PATHOGENESIS FROM MOUSE TO MAN, 2003, 1005 : 88 - 97
  • [3] Characterization of the CD8+T cell response in rickettsial infections
    Gomez, Erika Caro
    Cespedes, Maria
    Texeira, Bruno
    Gazi, Michal
    Valbuena, Gustavo
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [4] Defects in the CD8+T cell response to arthritogenic alphaviruses
    Bullock, Christopher B.
    Davenport, Bennett J.
    Morrison, Thomas E.
    Miller, Mark J.
    Diamond, Michael S.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [5] CD8+T Cells Differentiate into a Potent CD43+Effector Population During Acute Allograft Rejection
    Krummey, Scott
    Cohen, Gregory
    Kallarakal, Melissa
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [6] Antigen-specific CD8+T cell response are reduced by chronic ethanol and by TLR agonists: CD8+T cell alterations
    Gurung, Prajwal
    McGill, Jodi
    Young, Betty M.
    Coleman, Ruth A.
    Legge, Kevin L.
    Cook, Robert T.
    ALCOHOL, 2009, 43 (08) : 668 - 668
  • [7] Detection of Alloreactive CD8+T Cell Responses and the Immunopeptidome That Elicits Their Activation.
    Morris, A. B.
    Zhang, X.
    Peek, E. V.
    Hadley, A.
    Larsen, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 543 - 543
  • [8] Bystander CD8+T cells are Important Antiviral Effectors in the Brain
    Berger, Jennifer
    Monogue, Brendan
    Heiden, Dustin
    Klarquist, Jared
    Beckham, John David
    Berg, Leslie J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [9] Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+T cell reconstitution elicits consistent CD8+T cell responses
    Schmitt, Michael
    Schmitt, Anita
    Wiesneth, Markus
    Hueckelhoven, Angela
    Wu, Zeguang
    Kuball, Juergen
    Wang, Lei
    Schauwecker, Peter
    Hofmann, Susanne
    Goetz, Marlies
    Michels, Birgit
    Maccari, Birgit
    Wuchter, Patrick
    Eckstein, Volker
    Mertens, Thomas
    Schnitzler, Paul
    Doehner, Hartmut
    Ho, Anthony D.
    Bunjes, Donald W.
    Dreger, Peter
    Schrezenmeier, Hubert
    Greiner, Jochen
    THERANOSTICS, 2017, 7 (06): : 1705 - 1718
  • [10] Adenovirus vaccine therapy with CD137L promotes CD8+DCs-mediated multifunctional CD8+T cell immunity and elicits potent anti-tumor activity
    Ding, Jiage
    Jiang, Nan
    Zheng, Yanyan
    Wang, Jiawei
    Fang, Lin
    Li, Huizhong
    Yang, Jie
    Hu, Ankang
    Xiao, Pengli
    Zhang, Qing
    Chai, Dafei
    Zheng, Junnian
    Wang, Gang
    PHARMACOLOGICAL RESEARCH, 2022, 175